Your browser doesn't support javascript.
loading
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.
Soria, J-C; Cortes, J; Massard, C; Armand, J-P; De Andreis, D; Ropert, S; Lopez, E; Catteau, A; James, J; Marier, J-F; Beliveau, M; Martell, R E; Baselga, J.
Ann Oncol ; 30(6): 1020, 2019 06 01.
Article in En | MEDLINE | ID: mdl-30624604
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article